Brazil - Joint venture to develop TB molecular diagnostic kit

Brazilian institution is searching for partners for the development of a tuberculosis (TB) test.


A Brazilian public health research institute is looking for partners to develop a TB test that detects the agent and its resistance to the main treatment drugs.

The test should:

- be able to detect resistance of Mycobacterium tuberculosis to Rifampicin and isoniazid with high sensitivity and specificity
- perform the diagnosis on an unique molecular biology platform
- perform the diagnosis from clinical samples and/or cultures of mycobacteria
- be made in Brazil

The estimated value is £5.7 million per year.

Participation of more than one company, institution or organisation for the presentation of the same group proposal is allowed.

The Brazilian institute is located in the State of São Paulo.

Apply for more information from the Department for International Trade team in Brazil.

Essential information

Sectors:

Biotechnology & Pharmaceuticals and Healthcare & Medical

Opportunity type:

Public Sector

Expiry date:

03 July 2017

Applications received:

2

Value of contract:

More than £100k

Apply for this opportunity